X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with ASTRAZENECA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ASTRAZENECA PHARMA - Comparison Results

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ASTRAZENECA PHARMA DR. DATSONS LABS/
ASTRAZENECA PHARMA
 
P/E (TTM) x -10.9 93.7 - View Chart
P/BV x 0.2 13.3 1.2% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ASTRAZENECA PHARMA
Mar-14
DR. DATSONS LABS/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs1261,285 9.8%   
Low Rs31634 4.9%   
Sales per share (Unadj.) Rs133.0189.6 70.1%  
Earnings per share (Unadj.) Rs0.2-0.2 -74.5%  
Cash flow per share (Unadj.) Rs6.63.8 171.9%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.868.6 187.6%  
Shares outstanding (eoy) m31.6625.00 126.6%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.65.1 11.6%   
Avg P/E ratio x516.1-4,712.7 -11.0%  
P/CF ratio (eoy) x11.8249.6 4.7%  
Price / Book Value ratio x0.614.0 4.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,47723,988 10.3%   
No. of employees `000NA1.6 0.0%   
Total wages/salary Rs m561,605 3.5%   
Avg. sales/employee Rs ThNM3,040.2-  
Avg. wages/employee Rs ThNM1,029.2-  
Avg. net profit/employee Rs ThNM-3.3-  
INCOME DATA
Net Sales Rs m4,2114,740 88.8%  
Other income Rs m7992 85.5%   
Total revenues Rs m4,2894,832 88.8%   
Gross profit Rs m569-130 -438.1%  
Depreciation Rs m204101 202.0%   
Interest Rs m4300-   
Profit before tax Rs m13-139 -9.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0139 0.0%   
Tax Rs m65 119.8%   
Profit after tax Rs m5-5 -94.3%  
Gross profit margin %13.5-2.7 -493.1%  
Effective tax rate %48.0-3.7 -1,310.7%   
Net profit margin %0.1-0.1 -106.2%  
BALANCE SHEET DATA
Current assets Rs m6,8522,726 251.3%   
Current liabilities Rs m6,7112,435 275.6%   
Net working cap to sales %3.36.1 54.5%  
Current ratio x1.01.1 91.2%  
Inventory Days Days16174 218.1%  
Debtors Days Days31841 781.3%  
Net fixed assets Rs m3,6731,035 354.8%   
Share capital Rs m31750 633.2%   
"Free" reserves Rs m3,761942 399.1%   
Net worth Rs m4,0781,716 237.6%   
Long term debt Rs m1,6710-   
Total assets Rs m12,6334,156 304.0%  
Interest coverage x1.0NM-  
Debt to equity ratio x0.40-  
Sales to assets ratio x0.31.1 29.2%   
Return on assets %3.4-0.1 -2,811.6%  
Return on equity %0.1-0.3 -39.7%  
Return on capital %7.70-  
Exports to sales %22.95.7 401.6%   
Imports to sales %14.36.5 221.2%   
Exports (fob) Rs m964270 356.8%   
Imports (cif) Rs m602306 196.5%   
Fx inflow Rs m964375 257.3%   
Fx outflow Rs m607470 129.1%   
Net fx Rs m357-96 -373.5%   
CASH FLOW
From Operations Rs m1,345-8 -16,602.5%  
From Investments Rs m-2,256-146 1,548.1%  
From Financial Activity Rs m-1,200862 -139.2%  
Net Cashflow Rs m-2,111709 -297.9%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 0.3 -  
FIIs % 1.4 15.7 8.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 9.1 1,034.1%  
Shareholders   20,807 12,856 161.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   MERCK LTD  STERLING BIOTECH  JUBILANT LIFE SCIENCES  AUROBINDO PHARMA  IPCA LABS  

Compare DR. DATSONS LABS With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Securities & Intelligence Services Ltd. (IPO)

Jul 31, 2017

Should you subscribe to the IPO of Securities & Intelligence Services Ltd?

Why Super Investors are Underperforming in This Market (The 5 Minute Wrapup)

Jul 8, 2017

If Super Investors can wait for the right pitch, so can you.

Tejas Networks Ltd. (IPO)

Jun 14, 2017

Should you subscribe to the IPO of Tejas Networks Ltd?

Discover the Secrets of Hidden Smallcaps From These AGMs (The 5 Minute Wrapup)

May 26, 2017

Don't be surprised to come across some Super Investors there!

A Trader's Nightmare. A Business Owner's Delight. (The 5 Minute Wrapup)

May 19, 2017

Not all small-cap investors see themselves as traders. Some see themselves as business owners.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - AJANTA PHARMA COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS